Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for Nonalcoholic steatohepatitis (NASH) changes with S.Q. Leptin administrations (Study ST000677)

C18 POSITIVE ION MODE (Analysis AN001041)

Metabolite	Structure	F1	F2	F3	F4	F5	F6
MG 18:2; [M+NH4]+@2.36	ME187949	0.58	0.11	2.32	0.15	0.90	3.36
TG 62:13; [M+NH4]+@9.93	ME188104	0.83	0.50	0.31	1.05	1.20	1.71
TG 62:15; [M+NH4]+@9.70	ME188106	0.76	0.53	0.15	1.00	1.28	1.91
TG 60:13; [M+NH4]+@9.77	ME188098	0.86	0.33	0.38	1.33	0.56	1.73
TG 58:12; [M+NH4]+@9.62	ME188085	0.74	0.34	0.30	1.17	0.70	2.14
TG 62:14; [M+NH4]+@9.87	ME188105	0.94	0.55	0.17	1.08	0.65	2.10
TG 58:11; [M+NH4]+@9.80	ME188084	0.87	0.55	0.34	1.14	0.67	1.91
TG 60:12; [M+NH4]+@9.90	ME188097	0.79	0.54	0.32	1.19	0.68	1.92
TG 56:10; [M+NH4]+@9.72	ME188070	0.68	0.68	0.49	1.17	0.82	1.76
TG 58:10; [M+NH4]+@9.98	ME188083	1.01	0.63	0.48	1.13	0.63	1.65
TG 58:9; [M+NH4]+@10.18	ME188093	0.96	0.74	0.50	1.18	0.78	1.37
TG 60:11; [M+NH4]+@10.11	ME188096	0.98	0.73	0.48	1.16	0.73	1.45
TG 56:9; [M+NH4]+@9.86	ME188078	0.89	0.68	0.58	1.18	0.79	1.44
TG 60:10; [M+NH4]+@10.21	ME188095	0.98	0.70	0.56	1.13	0.82	1.41
DG 36:6; [M+NH4]+@6.66	ME187933	0.56	1.39	1.11	0.88	1.12	1.42
TG 54:0; [M+NH4]+@11.32	ME188049	0.59	1.15	1.17	1.05	0.82	1.40
lysoPC 20:3; [M+Na]+@1.36	ME188113	0.80	0.43	1.05	0.84	1.47	1.53
DG 38:7; [M+NH4]+@6.92	ME187940	0.72	0.84	1.00	0.84	1.11	1.74
PC 40:9; [M+H]+@5.53	ME187971	0.87	0.87	0.78	0.83	1.29	1.50
PC 38:8; [M+H]+@5.39	ME187966	1.23	0.59	1.37	0.69	1.30	1.15
plasmenyl-PC 40:0; [M+Na]+@8.61	ME188120	1.54	0.60	0.75	0.94	0.63	1.24
TG 56:8; [M+NH4]+@10.07	ME188077	1.21	0.55	0.26	1.24	0.79	1.17
TG 58:7; [M+NH4]+@10.47	ME188091	1.30	0.56	0.21	1.23	0.84	1.04
TG 56:6; [M+NH4]+@10.43	ME188075	1.46	0.70	0.30	1.13	0.75	0.99
PC 34:2; [M+H]+@6.32	ME187955	1.33	0.86	0.38	1.12	0.84	0.94
TG 52:2; [M+NH4]+@10.60	ME188035	1.35	0.95	0.46	1.09	0.85	0.86
TG 52:3; [M+NH4]+@10.42	ME188036	1.31	0.87	0.46	1.18	0.81	0.81
TG 58:5; [M+NH4]+@10.83	ME188089	0.96	0.96	0.68	1.25	0.73	0.99
TG 60:9; [M+NH4]+@10.39	ME188102	1.08	0.66	0.61	1.31	0.74	0.94
TG 52:4; [M+NH4]+@10.21	ME188037	1.18	0.84	0.47	1.28	0.77	0.79
TG 54:4; [M+NH4]+@10.46	ME188053	1.10	0.76	0.43	1.33	0.83	0.81
TG 52:5; [M+NH4]+@9.94	ME188038	1.12	0.78	0.44	1.35	0.72	0.83
TG 54:5; [M+NH4]+@10.27	ME188054	1.07	0.79	0.41	1.40	0.69	0.81
TG 60:7; [M+NH4]+@10.71	ME188100	1.09	0.43	0.71	1.37	0.96	0.63
TG 60:6; [M+NH4]+@10.96	ME188099	0.95	0.66	0.57	1.55	0.47	0.82
TG 62:9; [M+NH4]+@10.56	ME188107	0.64	0.52	0.70	1.50	0.87	0.97
PC 35:4; [M+Na]+@6.07	ME187957	1.06	1.58	1.08	0.93	0.84	0.81
TG 44:1; [M+NH4]+@9.83	ME188008	0.59	0.76	1.22	1.35	0.81	0.95
TG 44:2; [M+NH4]+@9.58	ME188009	0.49	0.79	1.23	1.45	0.75	0.87
DG 34:4; [M+NH4]+@6.82	ME187925	0.64	1.41	1.30	0.88	1.22	1.07
TG 49:0; [M+NH4]+@10.72	ME188017	0.61	1.35	1.40	0.99	1.09	0.95
PC 30:3; [M+H]+@5.39	ME187950	0.77	1.39	1.04	1.04	1.06	0.85
SM 43:2; [M+Na]+@8.28	ME188001	0.62	1.21	1.18	1.07	1.06	1.01
TG 56:0; [M+NH4]+@11.60	ME188068	0.70	1.23	1.24	1.03	1.13	0.89
SM 35:1; [M+Na]+@6.07	ME187984	0.86	1.16	1.18	1.02	0.98	0.93
TG 53:1; [M+NH4]+@10.98	ME188042	0.74	1.12	1.12	1.08	1.08	0.92
TG 49:1; [M+NH4]+@10.51	ME188018	0.80	1.08	1.39	1.01	1.14	0.81
TG 49:2; [M+NH4]+@10.30	ME188019	0.85	1.14	1.31	1.00	1.17	0.72
TG 51:1; [M+NH4]+@10.75	ME188028	0.89	1.15	1.35	0.93	1.16	0.81
DG 35:1; [M+NH4]+@8.24	ME187926	0.73	1.16	1.29	1.01	1.35	0.69
TG 48:1; [M+NH4]+@10.34	ME188014	0.74	0.98	1.47	1.06	1.28	0.63
TG 48:3; [M+NH4]+@9.92	ME188016	0.68	1.02	1.43	1.09	1.25	0.66
DG 34:0; [M+NH4]+@8.43	ME187922	0.79	0.86	1.38	1.00	1.07	1.04
DG 36:1; [M+NH4]+@8.50	ME187929	0.80	0.79	1.51	1.01	1.12	0.93
DG 34:2; [M+NH4]+@7.65	ME187923	0.90	0.93	1.42	0.96	1.26	0.75
TG 49:3; [M+NH4]+@10.09	ME188020	0.93	0.78	1.46	1.06	1.10	0.70
TG 55:0; [M+NH4]+@11.18	ME188059	0.90	0.77	0.99	0.99	1.43	0.89
DG 38:4; [M+NH4]+@7.91	ME187937	0.96	1.00	0.84	1.08	1.29	0.68
DG 40:5; [M+NH4]+@8.10	ME187941	0.88	0.83	1.11	1.13	1.34	0.57
TG 54:1; [M+NH4]+@11.10	ME188050	0.87	0.73	1.26	1.15	0.73	1.11
TG 58:3; [M+NH4]+@11.17	ME188087	0.94	0.75	1.08	1.23	0.70	0.96
SM 32:2; [M+Na]+@4.63	ME187979	1.08	0.77	1.33	1.03	0.76	1.00
DG 38:1; [M+NH4]+@8.62	ME187934	0.96	0.68	1.45	1.08	0.91	0.86
PC 39:8; [M+H]+@6.12	ME187968	1.00	0.82	1.36	1.12	0.80	0.80
TG 56:3; [M+NH4]+@10.92	ME188072	0.93	0.78	1.09	1.15	0.99	0.85
SM 42:0; [M+Na]+@8.04	ME187995	0.99	0.77	0.97	1.11	0.97	0.95
TG 58:1; [M+NH4]+@11.60	ME188082	1.02	0.70	1.03	1.14	0.89	0.91
TG 52:7; [M+NH4]+@9.70	ME188040	0.77	0.66	0.90	1.27	1.01	0.98
TG 51:5; [M+NH4]+@9.97	ME188032	0.83	0.86	0.96	1.20	0.93	0.94
TG 52:6; [M+NH4]+@9.84	ME188039	0.85	0.82	0.90	1.22	0.95	0.91
TG 51:3; [M+NH4]+@10.35	ME188030	1.19	0.78	0.62	1.17	1.01	0.73
PC 36:6; [M+H]+@5.98	ME187961	0.98	0.83	0.64	1.26	1.05	0.72
DG 36:2; [M+NH4]+@8.21	ME187930	1.04	0.80	0.80	1.16	1.06	0.77
plasmenyl-PC 31:0; [M+Na]+@5.41	ME188117	0.96	0.83	0.75	1.17	1.10	0.82
TG 48:2; [M+NH4]+@10.12	ME188015	1.06	1.08	0.79	1.16	0.85	0.79
TG 55:4; [M+NH4]+@10.62	ME188063	1.03	0.84	0.94	1.17	0.88	0.83
TG 55:5; [M+NH4]+@10.55	ME188064	1.03	0.88	0.91	1.13	1.01	0.77
TG 56:5; [M+NH4]+@10.60	ME188074	1.01	0.85	0.84	1.19	0.98	0.78
MG 15:1; [M+NH4]+@0.88	ME187944	1.10	0.91	0.79	1.08	0.94	0.93
TG 56:4; [M+NH4]+@10.77	ME188073	0.99	0.97	0.87	1.14	0.88	0.92
DG 36:3; [M+NH4]+@7.71	ME187931	0.97	0.61	1.31	1.08	1.21	0.69
PC 34:6; [M+H]+@5.31	ME187956	1.07	0.68	1.17	1.05	1.13	0.76
TG 53:3; [M+NH4]+@10.59	ME188044	1.01	0.77	1.11	1.09	1.10	0.76
DG 40:6; [M+NH4]+@7.75	ME187942	0.94	0.61	1.12	1.06	1.23	0.88
PC 31:0; [M+Na]+@5.71	ME187951	1.00	0.50	1.21	1.08	1.10	0.90
TG 53:4; [M+NH4]+@10.39	ME188045	0.98	0.63	1.14	1.12	1.04	0.85
TG 49:4; [M+NH4]+@9.88	ME188021	0.87	0.86	1.12	1.22	0.88	0.79
TG 51:4; [M+NH4]+@10.17	ME188031	0.92	0.78	1.24	1.18	1.00	0.67
TG 53:5; [M+NH4]+@10.20	ME188046	0.96	0.66	1.14	1.21	0.92	0.76
PC 42:11; [M+H]+@5.88	ME187972	0.87	0.74	1.20	1.10	1.01	0.96
TG 54:2; [M+NH4]+@10.80	ME188051	0.93	0.71	1.18	1.06	1.06	0.96
TG 53:6; [M+NH4]+@10.01	ME188047	0.84	0.65	1.28	1.14	1.09	0.83
TG 50:5; [M+NH4]+@9.77	ME188027	0.79	0.78	1.19	1.16	1.12	0.80
TG 52:0; [M+NH4]+@11.08	ME188033	0.72	0.77	1.16	1.21	1.07	0.86
PC 38:9; [M+Na]+@5.15	ME187967	0.84	0.94	0.97	1.14	1.09	0.84
TG 54:3; [M+NH4]+@10.68	ME188052	0.86	0.94	1.10	1.08	1.09	0.88
TG 53:2; [M+NH4]+@10.78	ME188043	0.86	0.91	1.23	1.04	1.22	0.78
TG 50:3; [M+NH4]+@10.16	ME188025	0.87	1.08	1.18	1.04	1.18	0.72
TG 50:4; [M+NH4]+@9.97	ME188026	0.83	0.98	1.21	1.11	1.16	0.70
DG 34:3; [M+NH4]+@7.20	ME187924	0.98	0.86	1.16	0.98	1.17	0.88
DG 38:3; [M+NH4]+@8.24	ME187936	1.03	0.94	1.25	1.00	1.06	0.78
TG 51:2; [M+NH4]+@10.55	ME188029	0.97	0.97	1.19	1.01	1.15	0.76
lysoPC 19:0; [M+H]+@2.99	ME188111	1.01	0.87	1.20	1.01	0.86	1.05
PC 36:7; [M+H]+@5.56	ME187962	0.95	0.89	1.14	1.06	0.86	1.03
lysoPC 24:1; [M+H]+@4.41	ME188116	0.89	0.90	1.19	1.04	0.91	1.08
TG 52:1; [M+NH4]+@10.85	ME188034	0.86	0.99	1.19	1.06	0.92	1.01
DG 36:5; [M+NH4]+@6.99	ME187932	0.83	0.96	1.18	1.01	1.06	1.05
SM 30:1; [M+Na]+@4.45	ME187977	0.83	0.90	1.08	1.08	1.02	1.04
TG 56:2; [M+NH4]+@11.12	ME188071	0.88	0.86	1.11	1.11	0.97	0.95
PC 35:5; [M+H]+@6.11	ME187958	0.96	1.13	1.13	1.06	0.96	0.80
SM 40:1; [M+Na]+@7.87	ME187991	1.00	1.07	1.17	1.03	0.92	0.86
SM 41:2; [M+Na]+@7.74	ME187994	1.10	1.02	1.01	0.97	0.98	0.94
SM 39:1; [M+Na]+@7.67	ME187990	1.11	0.98	1.12	1.00	0.92	0.87
SM 43:1; [M+Na]+@8.54	ME188000	1.01	0.95	1.08	1.02	0.96	0.94
SM 44:2; [M+Na]+@8.49	ME188002	0.99	0.95	0.99	1.11	0.96	0.85
DG 38:2; [M+NH4]+@8.43	ME187935	1.07	0.98	1.07	1.06	1.02	0.73
SM 40:2; [M+Na]+@7.46	ME187992	1.04	0.99	1.09	1.07	0.94	0.80
plasmenyl-PE 40:4; [M+H]+@7.88	ME188125	0.99	1.40	0.72	1.10	0.57	1.14
TG 50:1; [M+NH4]+@10.54	ME188023	1.19	1.24	0.61	1.09	0.71	0.93
TG 50:2; [M+NH4]+@10.36	ME188024	1.26	1.22	0.56	1.09	0.78	0.83
lysoPC 22:0; [M+H]+@4.37	ME188114	1.02	0.71	0.86	1.19	0.64	1.19
SM 42:5; [M]+@6.61	ME187999	1.21	0.76	1.00	1.08	0.73	0.97
TG 58:4; [M+NH4]+@10.97	ME188088	1.19	0.84	0.88	1.10	0.71	0.99
plasmenyl-PC 42:4; [M+Na]+@8.07	ME188122	1.07	0.86	0.73	0.97	0.83	1.43
CE(20:4); [M+NH4]+@10.56	ME187912	1.25	0.74	0.74	1.07	0.66	1.21
PC 36:4; [M+H]+@6.02	ME187960	1.17	0.84	0.74	1.05	0.77	1.17
TG 58:6; [M+NH4]+@10.65	ME188090	1.14	0.87	0.58	1.11	0.80	1.12
plasmenyl-PC 44:4; [M+Na]+@8.51	ME188124	1.17	1.03	0.60	1.05	0.70	1.20
plasmenyl-PC 44:4; [M+Na]+@8.63	ME188123	1.17	1.03	0.60	1.05	0.70	1.20
PC 42:5; [M+Na]+@7.66	ME187973	1.04	1.24	0.62	1.09	0.96	0.87
PE 35:1; [M+H]+@7.21	ME187976	0.86	1.30	0.73	1.10	1.07	0.88
PC 40:8; [M+H]+@6.61	ME187970	0.85	1.24	0.70	1.04	1.05	1.11
TG 55:1; [M+NH4]+@11.22	ME188060	0.95	1.37	0.67	0.89	1.21	1.08
lysoPC 20:2; [M+H]+@1.79	ME188112	0.97	1.07	0.87	0.91	1.05	1.24
lysoPC 22:4; [M+H]+@1.91	ME188115	1.05	1.15	0.82	0.84	0.94	1.40
PC 42:7; [M+H]+@7.60	ME187974	1.08	1.09	1.04	1.04	0.75	0.96
SM 41:1; [M+Na]+@8.18	ME187993	1.00	1.13	1.08	1.00	0.88	0.99
SM 33:1; [M+Na]+@5.60	ME187980	1.17	1.07	0.91	1.00	0.89	0.90
SM 34:2; [M+Na]+@5.39	ME187983	1.08	1.07	0.89	1.04	0.79	1.04
SM 42:4; [M]+@7.01	ME187998	1.08	1.13	0.84	1.06	0.79	0.99
PC 36:2; [M+H]+@6.97	ME187959	0.97	1.04	0.95	1.05	0.91	1.02
SM 32:1; [M+Na]+@5.21	ME187978	1.12	1.01	0.96	1.00	0.85	0.99
SM 33:2; [M]+@5.06	ME187981	1.05	0.97	0.98	1.01	0.87	1.06
CE(18:2); [M+NH4]+@10.66	ME187911	1.09	0.98	0.92	1.01	0.80	1.13
SM 42:1; [M+Na]+@8.43	ME187996	1.06	0.98	0.94	1.03	0.83	1.09
plasmenyl-PC 38:0; [M+Na]+@8.07	ME188119	1.11	0.93	0.77	0.97	0.89	1.23
plasmenyl-PC 40:3; [M+Na]+@8.08	ME188121	1.14	0.92	0.83	1.00	0.91	1.08
SM 34:1; [M]+@5.90	ME187982	1.14	0.92	0.81	1.03	0.82	1.10
SM 35:2; [M+Na]+@5.81	ME187985	1.06	1.13	0.75	0.96	0.93	1.16
SM 36:2; [M+Na]+@6.13	ME187987	1.22	1.14	0.79	0.92	0.88	1.08
PC 32:3; [M+H]+@6.13	ME187952	0.97	1.33	0.86	0.94	1.17	0.89
plasmenyl-PC 36:4; [M+Na]+@6.70	ME188118	1.08	0.99	0.95	0.93	1.12	0.99
PC 34:1; [M+H]+@6.79	ME187954	1.00	1.17	0.77	1.01	1.02	1.00
MG 17:0; [M+Li]+@3.20	ME187947	1.03	1.19	0.88	0.99	0.98	0.97
SM 42:2; [M+Na]+@7.93	ME187997	0.96	1.20	0.93	1.01	1.00	0.94
PC 32:4; [M+H]+@5.56	ME187953	0.90	1.09	0.90	1.02	1.02	1.08
SM 38:1; [M+Na]+@7.34	ME187988	0.94	1.06	0.98	1.00	1.08	0.97
TG 55:3; [M+NH4]+@10.82	ME188062	1.21	0.81	0.53	1.02	1.18	0.94
SM 38:2; [M+Na]+@6.81	ME187989	1.17	0.83	0.59	0.87	1.11	1.35
TG 57:9; [M+NH4]+@10.05	ME188081	1.15	0.67	0.54	1.00	1.01	1.31
DG 38:6; [M+NH4]+@7.30	ME187939	0.90	0.86	0.94	1.00	0.83	1.42
DG 36:0; [M+NH4]+@8.89	ME187928	0.82	0.76	1.09	1.03	0.88	1.39
lysoPC 18:2; [M+H]+@1.35	ME188110	0.79	0.87	1.13	0.95	0.97	1.43
PC 37:5; [M+Na]+@6.11	ME187963	0.89	0.63	1.24	1.01	1.02	1.18
PC 37:7; [M+H]+@6.05	ME187964	1.11	0.67	1.02	0.96	1.11	1.03
DG 38:5; [M+NH4]+@7.54	ME187938	1.05	0.84	1.12	0.90	1.06	1.13
lysoPC 16:0; [M+H]+@1.62	ME188108	1.00	0.80	1.07	0.97	0.91	1.23
lysoPC 18:0; [M+H]+@2.45	ME188109	0.99	0.81	1.00	0.97	0.98	1.24
TG 55:8; [M+NH4]+@10.02	ME188067	0.74	0.70	0.66	1.24	1.22	1.00
DG 40:8; [M+NH4]+@7.18	ME187943	0.82	0.54	0.83	1.13	0.93	1.43
TG 54:7; [M+NH4]+@9.92	ME188056	0.86	0.71	0.79	1.23	0.85	1.13
TG 54:8; [M+NH4]+@9.75	ME188057	0.80	0.71	0.76	1.24	0.92	1.15
TG 53:7; [M+NH4]+@9.83	ME188048	0.83	0.85	0.89	1.14	0.92	1.14
TG 54:6; [M+NH4]+@10.10	ME188055	0.94	0.89	0.87	1.18	0.79	1.05
PC 38:6; [M+H]+@6.21	ME187965	0.98	0.61	0.84	1.08	1.07	1.13
TG 55:6; [M+NH4]+@10.31	ME188065	0.94	0.64	0.81	1.05	1.05	1.30
TG 53:0; [M+NH4]+@11.20	ME188041	0.85	0.91	0.94	1.03	1.10	1.12
PC 40:10; [M+H]+@5.61	ME187969	0.77	0.72	0.89	1.12	1.04	1.26
plasmenyl-PE 42:6; [M+H]+@7.82	ME188126	0.84	0.72	0.82	1.10	0.98	1.31
TG 50:0; [M+NH4]+@10.82	ME188022	0.70	0.79	0.89	1.15	1.10	1.18
TG 55:2; [M+NH4]+@11.02	ME188061	0.82	0.76	0.85	1.14	1.08	1.09
PC 42:8; [M+H]+@7.21	ME187975	1.04	0.62	0.68	1.14	1.02	1.07
TG 55:7; [M+NH4]+@10.14	ME188066	1.05	0.69	0.71	1.16	0.95	1.02
TG 56:7; [M+NH4]+@10.23	ME188076	1.08	0.76	0.71	1.09	0.89	1.16
TG 58:8; [M+NH4]+@10.32	ME188092	0.99	0.73	0.60	1.19	0.86	1.15
TG 60:8; [M+NH4]+@10.57	ME188101	0.87	0.51	0.70	1.35	0.76	1.13
TG 54:9; [M+NH4]+@9.70	ME188058	0.92	0.56	0.62	1.22	0.83	1.30
TG 57:6; [M+NH4]+@10.57	ME188080	0.94	0.59	0.66	1.20	0.85	1.26
MG 16:1; [M+NH4]+@2.06	ME187946	0.69	0.53	1.79	0.54	1.74	1.54
MG 18:0; [M+NH4]+@3.72	ME187948	0.64	1.10	1.93	0.94	0.56	1.38
DG 30:0; [M+NH4]+@7.39	ME187913	0.51	0.85	2.51	0.75	1.79	0.53
DG 30:1; [M+NH4]+@6.93	ME187914	0.35	0.97	2.01	0.93	1.59	0.77
DG 31:0; [M+NH4]+@7.60	ME187915	0.57	0.97	2.01	0.90	1.55	0.62
DG 33:1; [M+NH4]+@7.76	ME187920	0.80	0.56	1.81	0.94	1.49	0.68
DG 35:2; [M+NH4]+@7.87	ME187927	0.73	0.87	1.72	1.06	1.38	0.43
DG 33:0; [M+NH4]+@8.15	ME187919	0.71	1.02	1.54	0.92	1.74	0.45
DG 32:0; [M+NH4]+@7.97	ME187916	0.73	1.06	1.73	0.84	1.49	0.72
DG 32:1; [M+NH4]+@7.51	ME187917	0.73	0.92	1.60	0.91	1.58	0.65
TG 62:1; [M+NH4]+@12.21	ME188103	0.47	0.50	2.11	1.01	1.22	1.04
SM 36:1; [M+Na]+@6.67	ME187986	0.81	0.83	1.79	1.06	0.96	0.73
TG 46:1; [M+NH4]+@10.08	ME188011	0.66	0.99	1.73	1.06	1.03	0.80
TG 46:2; [M+NH4]+@9.85	ME188012	0.56	0.90	1.83	1.14	1.11	0.66
TG 46:3; [M+NH4]+@9.65	ME188013	0.54	0.83	1.98	1.14	1.07	0.67
DG 32:2; [M+NH4]+@7.09	ME187918	0.83	0.92	1.91	0.91	1.20	0.68
TG 46:0; [M+NH4]+@10.33	ME188010	0.67	1.00	1.94	1.01	1.14	0.66
DG 33:2; [M+NH4]+@7.35	ME187921	0.74	0.58	1.31	1.13	1.25	0.88
TG 57:2; [M+NH4]+@11.25	ME188079	0.82	0.49	1.48	1.06	1.28	0.84
TG 60:1; [M+NH4]+@11.88	ME188094	0.64	0.60	1.85	1.02	1.03	1.12
TG 56:1; [M+NH4]+@11.34	ME188069	0.67	0.63	1.54	1.10	1.09	1.01
TG 58:2; [M+NH4]+@11.37	ME188086	0.64	0.63	1.68	1.14	1.01	0.95
MG 16:0; [M+NH4]+@2.81	ME187945	0.57	0.91	2.88	0.77	0.99	0.92
TG 40:0; [M+NH4]+@9.47	ME188003	0.20	0.67	2.56	1.38	0.76	0.61
TG 40:1; [M+NH4]+@9.18	ME188004	0.38	0.75	2.50	1.06	0.94	0.90
TG 42:2; [M+NH4]+@9.26	ME188007	0.34	0.90	2.18	1.26	0.82	0.72
TG 42:0; [M+NH4]+@9.79	ME188005	0.30	0.71	2.29	1.29	0.87	0.71
TG 42:1; [M+NH4]+@9.54	ME188006	0.27	0.77	2.24	1.24	0.97	0.76

Factors:

F1	visit:closeout
F2	visit:initial visit
F3	visit:intitial visit
F4	visit:month 1
F5	visit:month 12
F6	visit:visit 1

Data matrix